SCHEMBL27440665

SCHEMBL27440665

N#C/C(=C\c1cn(Cc2cccc(Cl)c2)c2ncccc12)C(O)O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SNCA P37840 7/20 0.61
▸ APP P05067 7/20 0.61
▸ ENPP2 Q13822 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ CNR1 P21554 2/20 0.40
▸ CNR2 P34972 2/20 0.40
▸ MAPT P10636 2/20 0.39
▸ THRB P10828 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ FSCN1 Q16658 1/20 0.37
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27440693 0.85 SNCA (0.53) SNCAAPPENPP2ALDH1A1KDM4E
SCHEMBL24163770 0.85 SNCA (0.62) SNCAAPPENPP2ALDH1A1HTT
SCHEMBL27440336 0.83 SNCA (0.63) SNCAAPPENPP2ALDH1A1KDM4E
SCHEMBL27440479 0.83 SNCA (0.53) SNCAAPPENPP2CNR1CNR2
SCHEMBL27440660 0.83 APP (0.59) SNCAAPPENPP2ALDH1A1KDM4E
SCHEMBL27440870 0.75 APP (0.47) SNCAAPPENPP2ALDH1A1KDM4E
SCHEMBL27440181 0.73 SNCA (0.76) SNCAAPPENPP2ALDH1A1KDM4E
SCHEMBL27440682 0.72 SNCA (0.56) SNCAAPPENPP2ALDH1A1CNR1
SCHEMBL24164332 0.72 APP (0.60) SNCAAPPENPP2ALDH1A1KDM4E
SCHEMBL27440352 0.72 SNCA (0.58) SNCAAPPENPP2ALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145369-A1 COMPOUNDS FOR TREATMENT OF HAIR LOSS PELAGE PHARMACEUTICALS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback